Updates matching "National"

WASHINGTON, D.C. – Nearly 5 00 cancer patients, survivors and their loved ones from all 50 states and nearly every congressional district will dial into calls and log onto virtual meeting s

The Trump administration issued an executive order Sunday that would significantly change how Medicare pays for certain prescription drugs. The “Most Favored Nation” policy would tie Medicare drug reimbursement for certain drugs under Part B and D t o that of prices paid in select foreign countries.

Today, the U.S. Senate voted on legislation aimed at addressing some of the issues stemming from the ongoing coronavirus pandemic. A statement from the leading coalition of the nation’s nonprofits follows:

Washington, D.C.—Patient groups representing millions of people with serious health conditions submitted an amicus brief today urging the full U.S. Court of Appeals for the D.C. Circuit to hear the case against a federal rule expanding the availability of short-term limited-duration insurance (STLDI) plans. The request

WASHINGTON, D.C. – U.S. Department of Health and Human Services (HHS) announced their decision Wednesday to rescind all guidance related to U.S. Food and Drug Administration (FDA) oversight of laboratory developed tests (LDTs), a move that could have broad, negative health consequences. The following is a statement from Lisa Lacasse,

A statement from Gary M. Reedy, CEO of the American Cancer Society and American Cancer Society Cancer Action Network (ACS CAN) on the death of civil rights champion and U.S. Congressman Rep. John Lewis from pancreatic cancer.

The American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN), support efforts to make nutrition research a federal priority.

Washington, D.C.—Today the House Appropriations Committee will vote on a proposed FY 2021 spending bill that includes a $5.5 billion funding increase for the National Institutes of Health (NIH)—half of which is emergency funding and the remainder of which will be divided among the various institutes, including a nearly $470

Setting a dangerous precedent that puts kids and public health at risk, today the U.S. Food and Drug Administration authorized the marketing of Philip Morris’ IQOS heated cigarette as a “modified risk tobacco product” despite the FDA’s acknowledgement that Philip Morris failed to show that IQOS presents a reduced risk of tobacco-related disease...